MediPal Holdings Corporation (TYO:7459)
Japan flag Japan · Delayed Price · Currency is JPY
2,929.50
-9.00 (-0.31%)
Sep 15, 2026, 11:30 AM JST

MediPal Holdings Company Description

MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan.

The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database.

It is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; and food processing raw materials for agriculture, fisheries, and livestock.

In addition, the company offers management and marketing support for insurance pharmacies; logistics contract; veterinary medicines and feed additives; and food processing raw materials, food ingredients, food additives, and chemical product materials.

It serves hospitals, clinics, pharmacies, drugstores, home centers, convenience store, supermarkets, veterinary clinics, livestock and fisheries businesses, processed food manufacturers, and other medical facilities.

The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to MediPal Holdings Corporation in October 2009.

The company was founded in 1898 and is headquartered in Chuo, Japan.

MediPal Holdings Corporation
CountryJapan
Founded1898
IndustryMedical Distribution
SectorHealthcare
Employees13,024
CEOShuichi Watanabe

Contact Details

Address:
3-1-1 Kyobashi
Chuo, 104-8461
Japan
Phone81 3 3517 5800
Websitemedipal.co.jp

Stock Details

Ticker Symbol7459
ExchangeTokyo Stock Exchange
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyJPY
ISIN NumberJP3268950007
SIC Code5122

Key Executives

NamePosition
Shuichi WatanabeChief Executive Officer
Hiroshi YarimizuChief Financial Officer
Toshihide YodaHead of Investor Relations